Back to results
US 2012/0252745 A1Published application
Novobiocin analogues having modified sugar moieties
AssigneeUniversity of Kansas
InventorsBrian S. J. Blagg, Huiping Zhao, Alison Catherine Donnelly
Life of this patent
Estimating the term…
Abstract
The disclosure provides novobiocin analogues with noviose replacements which are useful as Hsp90 inhibitors in the treatment of cancer.
Claims17
A compound according to Formula I:
- wherein:
- R1 is —NHCOR″, where R″ is a C1-C4 alkyl, aryl or heterocyclic group, each optionally substituted with one or more hydroxy, nitro, amino, alkyl, alkenyl, aryl, alkoxy or halo groups;
- X9 is —O-alkyl, —O-alkylamino, —O-cycloalkyl, —O—(CO)-alkyl, —O—(CO)-cycloalkyl, —O—(CH2)n-pyridinyl, —O—(CH2)n-piperidinyl, —O—(CH2)n-pyrrolino, or —O—(CH2)n-pyrrolidinyl, each substituted with one or more amino, amido, alkyl, alkoxy, halo, pyrrolidinyl, or hydroxyl groups;
- and where n is 0, 1 2 or 3;
- or —O-mono-hydroxylated furanose, —O-dihydroxylated furanose, —O-mono-hydroxylated pyranose, —O-dihydroxylated pyranose, —O-trihydroxylated pyranose, —O-mono-hydroxylatedoxepinose, —O-dihydroxylated oxepinose, —O-azasugar, —O-acyl, ester, amino, amido, carbamate, phosphate ester, tosylate or mesylate;
- or X9 is —OH provided that R″ is not of the structure:
- X is H, nitrile, halo, amino, amido, C1-C4 alkyl or alkoxy;
- and
- Y is H, amido, ester, amino, C1-C4 alkyl or alkoxy;
- or
- a pharmaceutically acceptable salt thereof.
8 more elements
Dependencies are inferred from the claim text.